These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 3064904

  • 1. Calculating costs of drug therapy: a review of a decade of literature (1977-1987).
    Simpson CA, Souney PF.
    Clin Ther; 1988; 10(6):616-50. PubMed ID: 3064904
    [Abstract] [Full Text] [Related]

  • 2. Economic value of out-of-hospital emergency care: a structured literature review.
    Lerner EB, Maio RF, Garrison HG, Spaite DW, Nichol G.
    Ann Emerg Med; 2006 Jun; 47(6):515-24. PubMed ID: 16713777
    [Abstract] [Full Text] [Related]

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE, Kleijnen J.
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [Abstract] [Full Text] [Related]

  • 4. [Pharmaco-economic evaluation of drug therapy osteoporosis. A literature review].
    Christensen PM, Brøsen K, Brixen KT, Beck-Nielsen H, Søgaard J, Kristiansen IS.
    Ugeskr Laeger; 2002 Mar 04; 164(10):1339-45. PubMed ID: 11894425
    [Abstract] [Full Text] [Related]

  • 5. Comparison of literature searches on quality and costs for health technology assessment using the MEDLINE and EMBASE databases.
    Topfer LA, Parada A, Menon D, Noorani H, Perras C, Serra-Prat M.
    Int J Technol Assess Health Care; 1999 Mar 04; 15(2):297-303. PubMed ID: 10507189
    [Abstract] [Full Text] [Related]

  • 6. Cost-benefit and cost-effectiveness analysis of drug therapy.
    Dao TD.
    Am J Hosp Pharm; 1985 Apr 04; 42(4):791-802. PubMed ID: 3925768
    [Abstract] [Full Text] [Related]

  • 7. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
    Huo MH, Muntz J.
    Clin Ther; 2009 Jun 04; 31(6):1129-41. PubMed ID: 19695383
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL, Wolf SL, Kabadi UM.
    Arch Intern Med; 1996 Feb 12; 156(3):259-64. PubMed ID: 8572835
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost comparisons among antimicrobial agents.
    Dudley M, Barriere S, Mills J.
    N Engl J Med; 1982 Sep 09; 307(11):689. PubMed ID: 7110220
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Defined daily dose--a suitable measure of therapy costs?].
    Heinzl S.
    Med Monatsschr Pharm; 1992 Jul 09; 15(7):193. PubMed ID: 1495443
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Measurement of cost-effectiveness of drug therapy. A symposium. Melbourne, July 17, 1989. Proceedings.
    Med J Aust; 1990 Aug 06; 153 Suppl():S1-24. PubMed ID: 2116579
    [No Abstract] [Full Text] [Related]

  • 16. [Expensive drugs and government measures].
    van der Kuy A.
    Tijdschr Ziekenverpl; 1983 Apr 12; 36(8):245-7. PubMed ID: 6552787
    [No Abstract] [Full Text] [Related]

  • 17. Astronomical costs.
    Mallegol DT.
    Surgery; 1988 Feb 12; 103(2):270. PubMed ID: 3340999
    [No Abstract] [Full Text] [Related]

  • 18. The costs of antibiotic therapy.
    Smith JM.
    N Z Med J; 1989 Sep 13; 102(875):483. PubMed ID: 2779913
    [No Abstract] [Full Text] [Related]

  • 19. [Cost evaluation of a side-effect of a drug].
    Royer RJ, Vidrequin A, Trechot P, Boissel P, Netter P.
    Presse Med; 1990 Jun 30; 19(26):1240. PubMed ID: 2142776
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.